Form 8-K - Current report:
SEC Accession No. 0001193125-12-333207
Filing Date
2012-08-03
Accepted
2012-08-03 06:09:00
Documents
6
Period of Report
2012-08-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d385300d8k.htm 8-K 24038
2 PLACEMENT AGENCY AGREEMENT d385300dex11.htm EX-1.1 119528
3 FORM OF COMMON STOCK PURCHASE WARRANT d385300dex41.htm EX-4.1 73288
4 OPINION OF COOLEY LLP d385300dex51.htm EX-5.1 9098
5 FORM OF SUBSCRIPTION AGREEMENT d385300dex101.htm EX-10.1 139949
6 GRAPHIC g385300g86n00.jpg GRAPHIC 2483
  Complete submission text file 0001193125-12-333207.txt   370787
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 121005138
SIC: 2835 In Vitro & In Vivo Diagnostic Substances